---
title: "最高法院驳回了药企试图停止医保价格谈判的请求"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/286922283.md"
description: "最高法院拒绝审理六家制药公司对医疗保险药品价格谈判的上诉。预计这一决定将为患者节省 15 亿美元，为医疗保险节省 60 亿美元的第一年支出。下级法院的持续法律挑战可能会导致未来的最高法院审查"
datetime: "2026-05-19T13:31:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286922283.md)
  - [en](https://longbridge.com/en/news/286922283.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286922283.md)
---

# 最高法院驳回了药企试图停止医保价格谈判的请求

High court decision: The Supreme Court refused to hear petitions from six drugmakers challenging Medicare’s drug price negotiations. Projected savings: Negotiated prices are expected to save patients $1.5 billion and Medicare $6 billion in the first year. Legal battles continue: Separate lawsuits are still pending in lower courts, potentially setting up future Supreme Court review.

### 相关股票

- [BMY.US](https://longbridge.com/zh-CN/quote/BMY.US.md)
- [JNJ.US](https://longbridge.com/zh-CN/quote/JNJ.US.md)
- [PILL.US](https://longbridge.com/zh-CN/quote/PILL.US.md)

## 相关资讯与研究

- [百时美施贵宝携手中国药企开展新药研发，开启全新跨国医药合作](https://longbridge.com/zh-CN/news/286589558.md)
- [百亿 ADC 抗癌药赛道迎新玩家，药企期待多元化支付提高可及性](https://longbridge.com/zh-CN/news/286547393.md)
- [强生重症肌无力治疗新药获国家药监局批准上市](https://longbridge.com/zh-CN/news/287196062.md)
- [药企战略运营：“数智化管理驾驶舱” 助力企业提质增效](https://longbridge.com/zh-CN/news/286884180.md)
- [药企何以在集采竞争中站稳脚跟](https://longbridge.com/zh-CN/news/286687274.md)